NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

局部皮膚感染疾病治療藥:市場分析,流行病學,市場預測 (2030年)

Topical Skin Infection Treatment - Market Insight, Epidemiology and Market Forecast - 2030

出版商 DelveInsight Business Research LLP 商品編碼 966734
出版日期 按訂單生產 內容資訊 英文 200 Pages
商品交期: 10個工作天內
價格
局部皮膚感染疾病治療藥:市場分析,流行病學,市場預測 (2030年) Topical Skin Infection Treatment - Market Insight, Epidemiology and Market Forecast - 2030
出版日期: 按訂單生產內容資訊: 英文 200 Pages
簡介

本報告提供全球主要7個國家──美國,歐洲主要5國 (EU5:法國·德國·義大利·西班牙·英國 ),日本──的局部皮膚感染疾病治療藥的疫情趨勢和今後的市場預測相關分析,彙整疾病·產品概要和市場基本結構,目前治療方法與未滿足需求,患病人數趨勢預測,已上市/臨床實驗中的治療藥的簡介,全球整體/各國的市場規模 (過去3年·今後11年份),主要的推動及阻礙市場要素等資訊,為您概述為以下內容。

目錄

第1章 主要考察

第2章 局部皮膚感染疾病治療藥:摘要整理

第3章 局部皮膚感染疾病治療藥的競爭資訊分析

第4章 局部皮膚感染疾病治療藥:市場概要

  • 整體市場佔有率結構 (2017年)
  • 整體市場佔有率結構 (2030年)

第5章 局部皮膚感染疾病治療藥:疾病概要

  • 簡介
  • 徵兆與症狀
  • 病理生理學
  • 危險因素
  • 診斷標準

第6章 患者治療流程

第7章 局部皮膚感染疾病的流行病學和患者人口

  • 流行病學分析的要點
  • 假設和理論的根據:主要7個國家
  • 流行病學方案:主要7個國家
    • 局部皮膚感染疾病:主要7個國家的流行病學方案 (2017年∼2030年)
  • 美國的疫情趨勢
    • 美國國內的局部皮膚感染疾病的流行病學方案 (2017年∼2030年)
  • 歐洲5個國家:各國疫情趨勢
    • 德國的疫情趨勢
    • 法國的疫情趨勢
    • 義大利的疫情趨勢
    • 西班牙的疫情趨勢
    • 英國的疫情趨勢
  • 日本的疫情趨勢

第8章 治療流程,目前治療·診療方法

  • 局部皮膚感染疾病的治療·管理方法
  • 局部皮膚感染疾病的治療流程

第9章 未滿足需求

第10章 局部皮膚感染疾病治療藥的主要端點

第11章 已上市產品

  • 主要7個國家所販售產品一覽
  • 藥名:企業名
    • 產品說明
    • 法規的里程碑
    • 其他開發活動
    • 重要的臨床實驗:概要

第12章 新治療藥

  • 主要產品一覽
  • 藥名:企業名
    • 產品說明
    • 其他開發活動
    • 臨床開發
    • 安全性和有效性
    • 產品簡介

第13章 局部皮膚感染疾病治療藥:主要7個國家的市場分析

  • 分析主要的要點
  • 局部皮膚感染疾病治療藥的市場規模:主要7個國家
  • 局部皮膚感染疾病治療藥的市場規模:主要7個國家,各治療藥物

第14章 屬性分析

第15章 主要7個國家:市場未來展望

  • 美國的市場規模
    • 局部皮膚感染疾病治療藥的整體市場規模
    • 市場規模:各治療藥物
  • 歐洲主要5個國家 (EU5) 市場:市場規模與未來展望
    • 德國的市場規模
    • 法國的市場規模
    • 義大利的市場規模
    • 西班牙的市場規模
    • 英國的市場規模
  • 日本市場:市場規模與未來展望

第16章 局部皮膚感染疾病治療藥的就醫與醫療費給付:概要

第13章 局部皮膚感染疾病治療:7個主要的市場分析

  • 主要調查結果
  • 主要7個國家的局部皮膚感染疾病治療市場規模
  • 主要7個國家的各治療法局部皮膚感染疾病治療的市場規模

第14章 屬性分析

第15章 主要7個國家:市場預測

  • 美國:市場規模
    • 美國局部皮膚感染疾病治療的整體市場規模
    • 美國的各治療法局部皮膚感染疾病治療的市場規模
  • 蚊子國:市場規模與展望歐洲5個國家
  • 德國的市場規模
    • 德國的局部皮膚感染疾病治療的整體市場規模
    • 德國的各治療法局部皮膚感染疾病治療的市場規模
  • 法國的市場規模
  • 義大利的市場規模
  • 西班牙的市場規模
  • 英國的市場規模
    • 英國的局部皮膚感染疾病治療的整體市場規模
    • 英國的各治療法局部皮膚感染疾病治療的市場規模
  • 日本市場預測
    • 日本的市場規模

第16章 局部皮膚感染疾病治療的存取(點閱)償付概要

第17章 產業的有學識者 (KOL)的見解

第18章 推動市場要素

第19章 市場阻礙因素

第20章 附錄

第21章 DelveInsight的服務內容

第22章 免責聲明

第23章 關於DelveInsight

目錄
Product Code: DIMI1137

DelveInsight's "Topical Skin Infection Treatment - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Topical Skin Infection Treatment , historical and forecasted epidemiology as well as the Topical Skin Infection Treatment market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Topical Skin Infection Treatment market report provides current treatment practices, emerging drugs, Topical Skin Infection Treatment market share of the individual therapies, current and forecasted Topical Skin Infection Treatment market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Topical Skin Infection Treatment treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Topical Skin Infection Treatment Disease Understanding and Treatment Algorithm

The DelveInsight Topical Skin Infection Treatment market report gives a thorough understanding of the Topical Skin Infection Treatment by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Topical Skin Infection Treatment .

Treatment

It covers the details of conventional and current medical therapies available in the Topical Skin Infection Treatment market for the treatment of the condition. It also provides Topical Skin Infection Treatment treatment algorithms and guidelines in the United States, Europe, and Japan.

Topical Skin Infection Treatment Epidemiology

The Topical Skin Infection Treatment epidemiology division provide insights about historical and current Topical Skin Infection Treatment patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Topical Skin Infection Treatment epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

Country Wise- Topical Skin Infection Treatment Epidemiology

The epidemiology segment also provides the Topical Skin Infection Treatment epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Topical Skin Infection Treatment Drug Chapters

Drug chapter segment of the Topical Skin Infection Treatment report encloses the detailed analysis of Topical Skin Infection Treatment marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Topical Skin Infection Treatment clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Topical Skin Infection Treatment treatment.

Topical Skin Infection Treatment Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Topical Skin Infection Treatment treatment.

Topical Skin Infection Treatment Market Outlook

The Topical Skin Infection Treatment market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Topical Skin Infection Treatment market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Topical Skin Infection Treatment market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Topical Skin Infection Treatment market in 7MM is expected to change in the study period 2017-2030.

Key Findings

This section includes a glimpse of the Topical Skin Infection Treatment market in 7MM.

The United States Market Outlook

This section provides the total Topical Skin Infection Treatment market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Topical Skin Infection Treatment market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Topical Skin Infection Treatment market size and market size by therapies in Japan is also mentioned.

Topical Skin Infection Treatment Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Topical Skin Infection Treatment market or expected to get launched in the market during the study period 2017-2030. The analysis covers Topical Skin Infection Treatment market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Topical Skin Infection Treatment Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Topical Skin Infection Treatment key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Topical Skin Infection Treatment emerging therapies.

Reimbursement Scenario in Topical Skin Infection Treatment

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Topical Skin Infection Treatment domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Topical Skin Infection Treatment market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Topical Skin Infection Treatment Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

  • The report covers the descriptive overview of Topical Skin Infection Treatment , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Topical Skin Infection Treatment epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Topical Skin Infection Treatment are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Topical Skin Infection Treatment market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Topical Skin Infection Treatment market

Report Highlights:

  • In the coming years, Topical Skin Infection Treatment market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Topical Skin Infection Treatment R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
  • Major players are involved in developing therapies for Topical Skin Infection Treatment . Launch of emerging therapies will significantly impact the Topical Skin Infection Treatment market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Topical Skin Infection Treatment
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Topical Skin Infection Treatment Report Insights

  • Patient Population
  • Therapeutic Approaches
  • Topical Skin Infection Treatment Pipeline Analysis
  • Topical Skin Infection Treatment Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies

Topical Skin Infection Treatment Report Key Strengths

  • 11 Years Forecast
  • 7MM Coverage
  • Topical Skin Infection Treatment Epidemiology Segmentation
  • Key Cross Competition
  • Highly Analyzed Market
  • Drugs Uptake

Topical Skin Infection Treatment Report Assessment

  • Current Treatment Practices
  • Unmet Needs
  • Pipeline Product Profiles
  • Market Attractiveness
  • Market Drivers and Barriers

Key Questions:

Market Insights:

  • What was the Topical Skin Infection Treatment market share (%) distribution in 2017 and how it would look like in 2030?
  • What would be the Topical Skin Infection Treatment total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Topical Skin Infection Treatment market size during the forecast period (2017-2030)?
  • At what CAGR, the Topical Skin Infection Treatment market is expected to grow in 7MM during the forecast period (2017-2030)?
  • What would be the Topical Skin Infection Treatment market outlook across the 7MM during the forecast period (2017-2030)?
  • What would be the Topical Skin Infection Treatment market growth till 2030, and what will be the resultant market Size in the year 2030?
  • How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

  • What is the disease risk, burden and unmet needs of the Topical Skin Infection Treatment ?
  • What is the historical Topical Skin Infection Treatment patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What would be the forecasted patient pool of Topical Skin Infection Treatment in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Topical Skin Infection Treatment ?
  • Out of all 7MM countries, which country would have the highest prevalent population of Topical Skin Infection Treatment during the forecast period (2017-2030)?
  • At what CAGR the population is expected to grow in 7MM during the forecast period (2017-2030)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

  • What are the current options for the Topical Skin Infection Treatment treatment, along with the approved therapy?
  • What are the current treatment guidelines for the treatment of Topical Skin Infection Treatment in the USA, Europe, and Japan?
  • What are the Topical Skin Infection Treatment marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
  • How many companies are developing therapies for the treatment of Topical Skin Infection Treatment ?
  • How many therapies are developed by each company for Topical Skin Infection Treatment treatment?
  • How many are emerging therapies in mid-stage, and late stage of development for Topical Skin Infection Treatment treatment?
  • What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Topical Skin Infection Treatment therapies?
  • What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Topical Skin Infection Treatment and their status?
  • What are the key designations that have been granted for the emerging therapies for Topical Skin Infection Treatment ?
  • What are the global historical and forecasted market of Topical Skin Infection Treatment ?

Reasons to buy:

  • The report will help in developing business strategies by understanding trends shaping and driving the Topical Skin Infection Treatment market
  • To understand the future market competition in the Topical Skin Infection Treatment market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Topical Skin Infection Treatment in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Topical Skin Infection Treatment market
  • To understand the future market competition in the Topical Skin Infection Treatment market

Table of Contents

1. Key Insights

2. Executive Summary of Topical Skin Infection Treatment

3. Competitive Intelligence Analysis for Topical Skin Infection Treatment

4. Topical Skin Infection Treatment : Market Overview at a Glance

  • 4.1. Topical Skin Infection Treatment Total Market Share (%) Distribution in 2017
  • 4.2. Topical Skin Infection Treatment Total Market Share (%) Distribution in 2030

5. Topical Skin Infection Treatment : Disease Background and Overview

  • 5.1. Introduction
  • 5.2. Sign and Symptoms
  • 5.3. Pathophysiology
  • 5.4. Risk Factors
  • 5.5. Diagnosis

6. Patient Journey

7. Topical Skin Infection Treatment Epidemiology and Patient Population

  • 7.1. Epidemiology Key Findings
  • 7.2. Assumptions and Rationale: 7MM
  • 7.3. Epidemiology Scenario: 7MM
    • 7.3.1. Topical Skin Infection Treatment Epidemiology Scenario in the 7MM (2017-2030)
  • 7.4. United States Epidemiology
    • 7.4.1. Topical Skin Infection Treatment Epidemiology Scenario in the United States (2017-2030)
  • 7.5. EU-5 Country-wise Epidemiology
    • 7.5.1. Germany Epidemiology
      • 7.5.1.1. Topical Skin Infection Treatment Epidemiology Scenario in Germany (2017-2030)
    • 7.5.2. France Epidemiology
      • 7.5.2.1. Topical Skin Infection Treatment Epidemiology Scenario in France (2017-2030)
    • 7.5.3. Italy Epidemiology
      • 7.5.3.1. Topical Skin Infection Treatment Epidemiology Scenario in Italy (2017-2030)
    • 7.5.4. Spain Epidemiology
      • 7.5.4.1. Topical Skin Infection Treatment Epidemiology Scenario in Spain (2017-2030)
    • 7.5.5. United Kingdom Epidemiology
      • 7.5.5.1. Topical Skin Infection Treatment Epidemiology Scenario in the United Kingdom (2017-2030)
    • 7.5.6. Japan Epidemiology
      • 7.5.6.1. Topical Skin Infection Treatment Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

  • 8.1. Topical Skin Infection Treatment Treatment and Management
  • 8.2. Topical Skin Infection Treatment Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Topical Skin Infection Treatment Treatment

11. Marketed Products

  • 11.1. List of Marketed Products in the 7MM
  • 11.2. Drug Name: Company Name
    • 11.2.1. Product Description
    • 11.2.2. Regulatory Milestones
    • 11.2.3. Other Developmental Activities
    • 11.2.4. Pivotal Clinical Trials
    • 11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

  • 12.1. Key Cross
  • 12.2. Drug Name: Company Name
    • 12.2.1. Product Description
    • 12.2.2. Other Developmental Activities
    • 12.2.3. Clinical Development
    • 12.2.4. Safety and Efficacy
    • 12.2.5. Product Profile

List to be continued in report

13. Topical Skin Infection Treatment : Seven Major Market Analysis

  • 13.1. Key Findings
  • 13.2. Topical Skin Infection Treatment Market Size in 7MM
  • 13.3. Topical Skin Infection Treatment Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

  • 15.1. United States: Market Size
    • 15.1.1. Topical Skin Infection Treatment Total Market Size in the United States
    • 15.1.2. Topical Skin Infection Treatment Market Size by Therapies in the United States
  • 15.2. EU-5 countries: Market Size and Outlook
  • 15.3. Germany Market Size
    • 15.3.1. Topical Skin Infection Treatment Total Market Size in Germany
    • 15.3.2. Topical Skin Infection Treatment Market Size by Therapies in Germany
  • 15.4. France Market Size
    • 15.4.1. Topical Skin Infection Treatment Total Market Size in France
    • 15.4.2. Topical Skin Infection Treatment Market Size by Therapies in France
  • 15.5. Italy Market Size
    • 15.5.1. Topical Skin Infection Treatment Total Market Size in Italy
    • 15.5.2. Topical Skin Infection Treatment Market Size by Therapies in Italy
  • 15.6. Spain Market Size
    • 15.6.1. Topical Skin Infection Treatment Total Market Size in Spain
    • 15.6.2. Topical Skin Infection Treatment Market Size by Therapies in Spain
  • 15.7. United Kingdom Market Size
    • 15.7.1. Topical Skin Infection Treatment Total Market Size in the United Kingdom
    • 15.7.2. Topical Skin Infection Treatment Market Size by Therapies in the United Kingdom
  • 15.8. Japan Market Outlook
    • 15.8.1. Japan Market Size
    • 15.8.2. Topical Skin Infection Treatment Total Market Size in Japan
    • 15.8.3. Topical Skin Infection Treatment Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Topical Skin Infection Treatment

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

  • 20.1. Bibliography
  • 20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

The table of contents is not exhaustive; the final content may vary.

List of Tables

  • Table 1: 7MM Topical Skin Infection Treatment Epidemiology (2017-2030)
  • Table 2: 7MM Topical Skin Infection Treatment Diagnosed and Treatable Cases (2017-2030)
  • Table 3: Topical Skin Infection Treatment Epidemiology in the United States (2017-2030)
  • Table 4: Topical Skin Infection Treatment Diagnosed and Treatable Cases in the United States (2017-2030)
  • Table 5: Topical Skin Infection Treatment Epidemiology in Germany (2017-2030)
  • Table 6: Topical Skin Infection Treatment Diagnosed and Treatable Cases in Germany (2017-2030)
  • Table 7: Topical Skin Infection Treatment Epidemiology in France (2017-2030)
  • Table 8: Topical Skin Infection Treatment Diagnosed and Treatable Cases in France (2017-2030)
  • Table 9: Topical Skin Infection Treatment Epidemiology in Italy (2017-2030)
  • Table 10: Topical Skin Infection Treatment Diagnosed and Treatable Cases in Italy (2017-2030)
  • Table 11: Topical Skin Infection Treatment Epidemiology in Spain (2017-2030)
  • Table 12: Topical Skin Infection Treatment Diagnosed and Treatable Cases in Spain (2017-2030)
  • Table 13: Topical Skin Infection Treatment Epidemiology in the UK (2017-2030)
  • Table 14: Topical Skin Infection Treatment Diagnosed and Treatable Cases in the UK (2017-2030)
  • Table 15: Topical Skin Infection Treatment Epidemiology in Japan (2017-2030)
  • Table 16: Topical Skin Infection Treatment Diagnosed and Treatable Cases in Japan (2017-2030)
  • Table 17: Drug Name, Clinical Trials by Recruitment status
  • Table 18: Drug Name, Clinical Trials by Zone
  • Table 19: Total Seven Major Market Size in USD, Million (2017-2030)
  • Table 20: Region-wise Market Size in USD, Million (2017-2030)
  • Table 21: 7MM-Market Size by Therapy in USD, Million (2017-2030)
  • Table 22: United States Market Size in USD, Million (2017-2030)
  • Table 23: United States Market Size by Therapy in USD, Million (2017-2030)
  • Table 24: Germany Market Size in USD, Million (2017-2030)
  • Table 25: Germany Market Size by Therapy in USD, Million (2017-2030)
  • Table 26: France Market Size in USD, Million (2017-2030)
  • Table 27: France Market Size by Therapy in USD, Million (2017-2030)
  • Table 28: Italy Market Size in USD, Million (2017-2030)
  • Table 29: Italy Market Size by Therapy in USD, Million (2017-2030)
  • Table 30: Spain Market Size in USD, Million (2017-2030)
  • Table 31: Spain Market Size by Therapy in USD, Million (2017-2030)
  • Table 32: United Kingdom Market Size in USD, Million (2017-2030)
  • Table 33: United Kingdom Market Size by Therapy in USD, Million (2017-2030)
  • Table 34: Japan Market Size in USD, Million (2017-2030)
  • Table 35: Japan Market Size by Therapy in USD, Million (2017-2030)

The list of tables is not exhaustive; the final content may vary

List of Figures

  • Figure 1: 7MM Topical Skin Infection Treatment Epidemiology (2017-2030)
  • Figure 2: 7MM Topical Skin Infection Treatment Diagnosed and Treatable Cases (2017-2030)
  • Figure 3: Topical Skin Infection Treatment Epidemiology in the United States (2017-2030)
  • Figure 4: Topical Skin Infection Treatment Diagnosed and Treatable Cases in the United States (2017-2030)
  • Figure 5: Topical Skin Infection Treatment Epidemiology in Germany (2017-2030)
  • Figure 6: Topical Skin Infection Treatment Diagnosed and Treatable Cases in Germany (2017-2030)
  • Figure 7: Topical Skin Infection Treatment Epidemiology in France (2017-2030)
  • Figure 8: Topical Skin Infection Treatment Diagnosed and Treatable Cases in France (2017-2030)
  • Figure 9: Topical Skin Infection Treatment Epidemiology in Italy (2017-2030)
  • Figure 10: Topical Skin Infection Treatment Diagnosed and Treatable Cases in Italy (2017-2030)
  • Figure 11: Topical Skin Infection Treatment Epidemiology in Spain (2017-2030)
  • Figure 12: Topical Skin Infection Treatment Diagnosed and Treatable Cases in Spain (2017-2030)
  • Figure 13: Topical Skin Infection Treatment Epidemiology in the UK (2017-2030)
  • Figure 14: Topical Skin Infection Treatment Diagnosed and Treatable Cases in the UK (2017-2030)
  • Figure 15: Topical Skin Infection Treatment Epidemiology in Japan (2017-2030)
  • Figure 16: Topical Skin Infection Treatment Diagnosed and Treatable Cases in Japan (2017-2030)
  • Figure 17: Drug Name, Clinical Trials by Recruitment status
  • Figure 18: Drug Name, Clinical Trials by Zone
  • Figure 19: Total Seven Major Market Size in USD, Million (2017-2030)
  • Figure 20: Region-wise Market Size in USD, Million (2017-2030)
  • Figure 21: 7MM-Market Size by Therapy in USD, Million (2017-2030)
  • Figure 22: United States Market Size in USD, Million (2017-2030)
  • Figure 23: United States Market Size by Therapy in USD, Million (2017-2030)
  • Figure 24: Germany Market Size in USD, Million (2017-2030)
  • Figure 25: Germany Market Size by Therapy in USD, Million (2017-2030)
  • Figure 26: France Market Size in USD, Million (2017-2030)
  • Figure 27: France Market Size by Therapy in USD, Million (2017-2030)
  • Figure 28: Italy Market Size in USD, Million (2017-2030)
  • Figure 29: Italy Market Size by Therapy in USD, Million (2017-2030)
  • Figure 30: Spain Market Size in USD, Million (2017-2030)
  • Figure 31: Spain Market Size by Therapy in USD, Million (2017-2030)
  • Figure 32: United Kingdom Market Size in USD, Million (2017-2030)
  • Figure 33: United Kingdom Market Size by Therapy in USD, Million (2017-2030)
  • Figure 34: Japan Market Size in USD, Million (2017-2030)
  • Figure 35: Japan Market Size by Therapy in USD, Million (2017-2030)

The list of figures is not exhaustive; the final content may vary.